Starpharma’s loss, strong financial position Biotechnology company Starpharma‘s loss narrowed during FY24 by 48 percent from $15.6 million to $8.2...
Vous n'êtes pas connecté
Orthocell’s strong sales growth Tissue regeneration technology developer Orthocell has announced sales growth across its product portfolio, with total revenue for FY24 of $6.72 million – up 30.40 peercent from FY23. Record revenue of $1.84m was achieved for the June 24 Quarter, up 14.41 percent. With Striate+ currently sold in the US, Europe/UK, Australia and… The post Manufacturing news briefs — stories you might have missed appeared first on Australian Manufacturing Forum.
Starpharma’s loss, strong financial position Biotechnology company Starpharma‘s loss narrowed during FY24 by 48 percent from $15.6 million to $8.2...
IDT Australia secures Sanofi contract Pharmaceutical development company IDT Australia has secured a follow on contract with pharma giant Sanofi...
CST extends its Olympics efforts at Paris Carbon fibre specialist CST Composites (pictured) shared this week that it supplied mast sections for the...
Alpha HPA begins work on second stage battery metals plant Aluminium chemicals company Alpha HPA has begun site construction activities for Stage 2 of...
News You Might Have Missed
News You Might Have Missed
Hearing implant manufacturer Cochlear has reported sales revenue up 15 percent to $2.3 billion for FY24, with growth across all business units....
Food producer and manufacturer Ingham’s Group has reported an EBITDA of $471.1 million for FY24 up 12.6 percent on FY23 as it focused on...
HF radio and metal detection manufacturer Codan has announced FY24 group earnings before interest and tax of $113.9 million, up 29 percent on the...
Australia’s most successful manufacturer, biotechnology company CSL today reported net profit after tax of $2.64 billion for the 12 months ended 30...